Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expression

Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by dysregulation of cytokines, apoptosis, and B- and T-cell functions. The tolerogenic peptide, hCDR1 (Edratide), ameliorated the clinical manifestations of murine lupus via down-regulation of pro-inflammatory cytokines and a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of autoimmunity 2009-08, Vol.33 (1), p.77-82
Main Authors: Sthoeger, Zev M., Sharabi, Amir, Molad, Yair, Asher, Ilan, Zinger, Heidy, Dayan, Molly, Mozes, Edna
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!